Denali Advisors LLC lifted its stake in Amdocs Limited (NASDAQ:DOX – Free Report) by 10.1% in the 2nd quarter, HoldingsChannel reports. The institutional investor owned 7,611 shares of the technology company’s stock after purchasing an additional 700 shares during the quarter. Denali Advisors LLC’s holdings in Amdocs were worth $601,000 at the end of the most recent reporting period.
Other large investors have also added to or reduced their stakes in the company. Norwood Financial Corp bought a new stake in shares of Amdocs during the 1st quarter valued at $33,000. Central Pacific Bank Trust Division acquired a new position in Amdocs in the first quarter valued at about $53,000. Riverview Trust Co bought a new stake in Amdocs during the first quarter worth about $55,000. Quarry LP grew its stake in Amdocs by 168.9% during the fourth quarter. Quarry LP now owns 656 shares of the technology company’s stock worth $58,000 after buying an additional 412 shares in the last quarter. Finally, Principal Securities Inc. bought a new position in Amdocs in the 4th quarter valued at about $63,000. Institutional investors and hedge funds own 92.02% of the company’s stock.
Amdocs Stock Performance
Amdocs stock opened at $86.41 on Wednesday. The company has a quick ratio of 1.24, a current ratio of 1.24 and a debt-to-equity ratio of 0.21. The stock has a market cap of $10.16 billion, a PE ratio of 19.42, a P/E/G ratio of 1.52 and a beta of 0.74. Amdocs Limited has a 12-month low of $74.41 and a 12-month high of $94.04. The business’s 50-day moving average price is $84.41 and its two-hundred day moving average price is $84.07.
Amdocs Announces Dividend
The company also recently declared a quarterly dividend, which will be paid on Friday, October 25th. Stockholders of record on Monday, September 30th will be paid a dividend of $0.479 per share. This represents a $1.92 dividend on an annualized basis and a dividend yield of 2.22%. The ex-dividend date of this dividend is Monday, September 30th. Amdocs’s payout ratio is 42.92%.
Wall Street Analysts Forecast Growth
Separately, StockNews.com upgraded shares of Amdocs from a “buy” rating to a “strong-buy” rating in a research report on Friday, September 13th. One investment analyst has rated the stock with a hold rating, three have assigned a buy rating and one has issued a strong buy rating to the company’s stock. According to data from MarketBeat.com, the company has a consensus rating of “Buy” and an average price target of $102.50.
Get Our Latest Research Report on Amdocs
Amdocs Profile
Amdocs Limited, through its subsidiaries, provides software and services worldwide. It designs, develops, operates, implements, supports, and markets open and modular cloud portfolio. The company provides CES23, a 5G and cloud-native microservices-based market-leading customer experience suite, that enables service providers to build, deliver, and monetize advanced services; Amdocs Subscription Marketplace, a software-as-a-service-based platform that includes an expansive network of pre-integrated digital services, such as media, gaming, eLearning, sports, and retail to security and business services; the monetization suite for charging, billing, policy, and revenue management; Intelligent networking suite with a set of modular, flexible, and open service lifecycle management capabilities for network automation journeys; amAIz, a telco GenAI framework; Amdocs Digital Brands Suite, a pre-integrated digital business suite; and Amdocs eSIM Cloud for service providers.
Read More
- Five stocks we like better than Amdocs
- What is the NASDAQ Stock Exchange?
- Galmed Pharmaceuticals Surges 400%: What’s Behind the Explosion?
- Investing in Travel Stocks Benefits
- Gold Hits New All-Time Highs: 3 Stocks to Ride the Surge
- What Are Dividend Challengers?
- Intel: Why It’s Time to Reconsider This Beaten-Down Chipmaker
Want to see what other hedge funds are holding DOX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Amdocs Limited (NASDAQ:DOX – Free Report).
Receive News & Ratings for Amdocs Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Amdocs and related companies with MarketBeat.com's FREE daily email newsletter.